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Abstract 
Objective: To estimate the proportion of over-the-counter antibiotic requests or consultations 
that resulted in non-prescription supply of antibiotics in community pharmacies globally. 
Methods: We systematically searched EMBASE, Medline and CINAHL databases for studies 
published from January 2000 to September 2017 reporting the frequency of non-prescription 
sale and supply of antibiotics in community pharmacies across the world. Additional articles 
were identified by checking reference lists and a Google Scholar search. A random effects 
meta-analysis was conducted to calculate pooled estimates of non-prescription supply of 
antibiotics. 
Results: Of the 3302 articles identified, 38 studies from 24 countries met the inclusion criteria 
and were included in the review. All the included countries with the exception of one, classified 
antibiotics as prescription-only medicines. The overall pooled proportion of non-prescription 
supply of antibiotics was 62% (95% CI 53 – 72). The pooled proportion of non-prescription 
supply of antibiotics following a patient request was 78% (95% CI 59 - 97) and based on 
community pharmacy staff recommendation was 58% (95% CI 48 – 68). The regional supply 
of non-prescription antibiotics was highest in South America, 78% (95% CI 72 - 84). Antibiotics 
were commonly supplied without a prescription to patients with symptoms of urinary tract 
infections (68%, 95% CI 42 – 93) and upper respiratory tract infections (67%, 95% CI 55 - 79). 
Fluoroquinolones and Penicillins respectively were the most commonly supplied antibiotic 
classes for these indications. 
Conclusion: Antibiotics are frequently supplied without prescription in many countries. This 
overuse of antibiotics could facilitate the development and spread of antibiotic resistance. 
 
Keywords: antibiotics; non-prescription supply; community pharmacies; infections; antibiotic 
stewardship. 
 
 
 
 
 
Introduction  
Antibiotics are the most frequently prescribed medicines world-wide.1 Between 2000 and 
2010, consumption of antibiotics increased from approximately 50 billion to 70 billion standard 
units.1 More than three-quarters of the overall increase in consumption of antibiotics occurred 
in Brazil, Russia, India, China, and South Africa.1 This global increase in consumption has 
been driven by a number of factors including economic growth and access to antibiotics.1 
However, the growing access to and use of antibiotics (either through prescription or non-
prescription) has been linked to antibiotic resistance, which is a significant threat to global 
public health.1-3 Antibiotic resistance accounts for more than 2 million infections and at least 
23,000 deaths annually in the USA 4 and about 25,000 deaths in Europe 5. Although reliable 
estimates of the burden of antibiotic-resistant infections in developing countries are lacking, it 
is believed to cause many more deaths in these countries. For example, in India alone, about 
57,000 neonatal sepsis deaths occurring annually are due to antibiotic-resistant infections.5 
About 80% of antibiotics are used in the community.6 These antibiotics are either prescribed 
by a healthcare professional or purchased directly by consumers without a valid prescription 
from many sources including community pharmacies. In many countries, the dispensing of 
antibiotics without a prescription is illegal. Nevertheless, over 50% of antibiotics worldwide are 
obtained without a prescription and community pharmacies are a major source of non-
prescribed antibiotics.7  This practice is particularly common in developing countries where 
there are no regulations regarding the sale and distribution of medicines or the enforcement 
of these regulations is weak.8, 9  Recent evidence has indicated that dispensing antibiotics 
without a prescription is becoming a problem in developed countries including Portugal and 
Spain.10, 11   
Non-prescription use of antibiotics is often associated with incomplete/shorter treatment 
courses and inappropriate drug and dose choices.12-14 Such irrational use of antibiotics could 
have a number of consequences including the development and spread of resistance to 
antibiotics, delayed hospital admissions and masking the diagnosis of infectious diseases.12-
15 For example, tuberculosis symptoms suppressed temporarily through the use of 
fluoroquinolones could delay its diagnosis and lead to the patients receiving several antibiotic 
courses for the wrong diagnosis.15  While in recent times, several interventions designed to 
optimise the use of antibiotics have been developed, they are often  targeted at hospitals 
thereby missing the non-prescription sources of antibiotics.16  
To address the problem of non-prescription use of antibiotics, an understanding of the 
magnitude of the practice and circumstances in which it occurs is important in the first 
instance. Previous reviews have focussed on the frequency of non-prescribed use of 
antibiotics in the  general population and have identified community pharmacies as important 
sources of these antibiotics.16, 17 However, the review by Morgan et al.,16  provided additional 
analysis on the frequency of community pharmacists’ recommendation of non-prescribed 
antibiotics. The analysis by Morgan et al.,16  was limited to 13 studies and without specific 
estimates by country, region or symptom. Hence, a more robust and updated analysis is 
needed. Therefore, we estimated the frequency of the supply of antibiotics without a 
prescription in community pharmacies globally identifying regions where this practice 
commonly occurs, the disease conditions commonly treated with non-prescribed antibiotics 
and the types of antibiotics commonly supplied without a prescription in community 
pharmacies.  
Methods 
Search strategy 
We searched EMBASE, Medline and CINAHL to identify studies published from January 2000 
to September 2017 that reported the sale and dispensing of non-prescribed antibiotics in 
community pharmacies. Search terms used including antibiotics, community pharmacy, sales 
and dispensing were combined using Boolean operators (See Box1). Additional articles were 
identified by checking reference lists and Google scholar search. No language or geographical 
restrictions were applied to the search. The research protocol was registered in the 
PROSPERO international prospective register of systematic reviews (CRD42017058156). 
Eligibility criteria for included studies 
Two reviewers, AA and DA independently screened studies against the inclusion and 
exclusion criteria with a Kappa agreement of 91.9%. Discrepancies were resolved through 
consensus. We included observational and experimental studies that reported the proportion 
of over-the-counter antibiotic requests or consultations in relation to symptoms of suspected 
infectious diseases that resulted in non-prescription supply of antibiotics in community 
pharmacies. Population-based surveys that explored pharmacists’ and public opinions on the 
supply and/or sources of non-prescription antibiotics were excluded. We also excluded 
qualitative studies (with no quantitative measures of non-prescription supply of antibiotics), 
reviews, editorials and conference reports.  
Assessment of risk of bias of included studies 
All studies were assessed for quality and risk of bias on eight criteria modelled largely from 
the ‘Strengthening the Reporting of Observational Studies in Epidemiology framework’.18 
These criteria were: detailed description of research setting, sample size, sampling strategy, 
clear definition of clinical/product-request scenario, reliability of measurement, social 
desirability, statistical analysis methods and generalisability of results. Each risk of bias criteria 
was assessed as low (scored as 1), moderate/high or unclear (scored as 0). The total score 
for each study was computed.    All studies were classified into one of the three levels of bias 
depending on their total scores, 0-2 (high risk), 3-5 (moderate risk) and 6-8 (low risk). 
Data extraction 
Data were extracted by two reviewers (AA & DA) and any discrepancy was resolved by 
consensus. The following data were extracted; author, year of publication, study country, 
sample size, number of visits/interactions observed, proportion of non-prescribed sale and 
supply of antibiotics. Other data extracted include; types of symptoms/disease conditions 
treated, types of antibiotics dispensed and nature of information given during consultation.  
Data analysis 
Statistical analyses were performed using Stata version 13.1 (StataCorp. LP, College Station, 
USA).  A random effects meta-analysis based on the DerSimonian and Laird approach,19 was 
conducted to calculate pooled  proportions  (with 95% confidence interval) of the supply of 
non-prescribed antibiotics for all included studies. The proportion of non-prescription supply 
of antibiotics in this study was calculated as the percentage of over-the-counter antibiotic 
requests or consultations in relation to symptoms of infectious diseases that resulted in the 
supply of antibiotics without a prescription. Proportion data were also pooled by symptoms of 
disease conditions, study period and types of antibiotics dispensed.  I-squared (I2) statistics 
were determined to assess the degree of heterogeneity across studies. Sub-group and meta-
regression analyses were conducted to explore the causes of heterogeneity. The co-variates 
considered included geographical region, study period, sampling procedure (random vs 
convenience sampling), number of community pharmacies, type of simulated scenario, 
category of pharmacy staff, concealment in methodology and each risk of bias criteria. Co-
variates were first tested individually and only those with p-values below 0.01 were included 
in the multivariate model. We performed sensitivity analysis to examine the effect of outliers 
and test the robustness of our findings. 
Results 
Study selection and characteristics 
We identified 3302 articles through the literature search, of which 38 met the inclusion criteria 
(see figure 1). The 38 studies were conducted in 24 countries and involved 8085 interactions 
within 6353 community pharmacies. Antibiotics are classified as prescription-only medicines 
in all the countries included in this review with the exception of Thailand. In Thailand, 
pharmacists are legally allowed to supply some antibiotics without a prescription.  
The majority of the studies (23 out of 38) included in this review were conducted in Asia. 
Almost all (37 out of 38) of the included studies were of cross-sectional design (Table 1). All 
included studies used simulated patient methodology with 35 of the 38 studies involving 
simulated-patient with concealed identities. The remaining three studies were based on 
pharmacy staff interviews using simulated scenarios.  A range of scenarios were simulated in 
the included studies with the most common involving symptoms of upper respiratory tract 
infections (URTI), gastroenteritis and urinary tract infections (UTI) in women of childbearing 
age (Table 1).  
The risk of bias assessment found that 15 (39%) studies had a low risk of bias while the 
remaining 23 (61%) studies had a moderate risk. The most common source of bias among 
the included studies was due to sampling (26/38, 68%) and half of the included articles (19/38) 
did not report a justification for the sample sizes used in their studies.  
Pooled estimates of the supply of antibiotics without prescription 
The overall pooled estimate of non-prescription supply of antibiotics was 62% (95% CI 53 – 
72) (Figure 2). This global estimate was comparable to the estimate for Asia (65%, 95% CI 54 
– 76), the most studied region. The pooled estimate for Southern and Eastern Europe (53%, 
95% CI 33 – 72) was comparable to that of Africa (57% 95% CI 16 - 99). The pooled estimate 
for Africa, was lower than those for Asia (65%, 95% CI 54 – 76) and South America (78% 95% 
CI 72 - 84). This was due to the low prevalence in the Zimbabwean study (Figure 2). Sensitivity 
analysis conducted by excluding the Zimbabwean study yielded a pooled estimate of 74% 
(95% CI 63 – 85) for Africa. However, the overall proportion (64%, 95% CI 55 – 73) of non-
prescription supply of antibiotics in community pharmacies was similar to the estimate 
obtained before the sensitivity analysis. Generally, non-prescription supply of antibiotics was 
more frequent in Indonesia (91%, 95% CI 86 – 94), Syria (87%, 95% CI 82 – 91), Saudi Arabia 
(85% 95% CI 72 – 99) and Ethiopia (85% 95% CI 75 – 92) (Figure 3). 
Seven studies presented data on the proportion of non-prescription supply of antibiotics 
following a specific product request by patients. The figures ranged from 16% (95% CI 10 – 
22) in Spain 20 to 98% (95% CI 94 – 102) in Saudi Arabia 21. The pooled estimate was 78% 
(95% CI 59 - 97). Similarly, the proportion of non-prescription supply of antibiotics based on 
pharmacy staff recommendation following the presentation of clinical symptoms  to them 
ranged from 8% (95% CI 4 -12) in Zimbabwe 22 to 94% (95% CI 92 – 98) in India 23. The pooled 
estimate based on pharmacy staff recommendation was 58% (95% CI 48 – 68) (Figure 4).   
Subgroup meta-analysis showed a significant difference between the pooled proportions of 
studies conducted from 2000 -2005 and 2011-2017 with estimates of 80% (95%CI 76 – 85) 
and 56% (95% CI 43 – 69), respectively (Table 2). Overall, substantial heterogeneity was 
observed on the pooled estimate of non-prescription supply of antibiotics (X2 = 4239.0, p < 
0.001, I2= 99.1%). Of the sources of variation investigated through meta-regression, only 
number of community pharmacies, study period and three quality criteria (reliability of 
measurement, statistical analysis methods and generalisability of results) had p values below 
0.10. These covariates yielded a significant multivariate model (p = 0.0193) that explained 
25.3% of between-study variation.  
Pooled estimates by symptom category 
The proportion of non-prescription supply of antibiotics among patients with symptoms of 
upper respiratory tract infections (URTI) ranged from 19% (95% CI 15 – 22) in a study in 
Bosnia and Herzegovina 24  to 99% (95% CI 97 -100) in Vietnam 25. The pooled estimate for 
URTI was 67% (95% CI 55 – 79) (Table 3). Penicillins were the most commonly recommended 
and supplied medicines to treat symptoms of URTI (Figure 5).  Pooled analysis by individual 
type of antibiotics supplied revealed that amoxicillin 53% (95% CI 34-71; I2=98.0, p<0.001), 
amoxicillin-clavulanic acid (co-amoxiclav) 39% (95% CI 23-54; I2 =97.4, p<0.001) and 
azithromycin 19% (95% CI 11-27; I2=96.2, p<0.001) were commonly supplied for URTI.  
The pooled estimates of non-prescription supply of antibiotics to patients with symptoms of 
urinary tract infections (UTI) and acute gastroenteritis were 68% (95% CI 42-93) and 63% 
(95% CI 46-80), respectively. Fluoroquinolones (69%, 95% CI 50-88) including ciprofloxacin 
and norfloxacin were commonly supplied for UTI while metronidazole (55%, 95% CI 29-81) 
was the most commonly supplied non-prescription antibiotic for acute gastroenteritis.  
Two studies investigated non-prescription supply of antibiotics in patients with persistent 
pulmonary tuberculosis. The proportions of non-prescription supply of antibiotics in these 
studies were 27% (95% CI 25-30) and 24% (95% CI 18-31) in India and Cambodia, 
respectively.  
Nature of consultation and advice given 
The proportion of patients that were referred to a medical prescriber without supplying an 
antibiotic ranged from 3% (95% CI 1 - 6) in a study in Indonesia 26 to 38% (95% CI 35 - 40) in 
a study in India.15 The pooled estimate for referral was 21% (95% CI 14 - 28).  
Very few consultations that resulted in non-prescription supply of antibiotics enquired about 
the patients’ drug history (12%, 95% CI 4-19) and allergies (32%, 95%CI 11-53) (Table 4). 
The pooled proportion of the number of consultations with pharmacy staff that resulted in the 
provision of information regarding the dose and duration of treatment with the supplied 
antibiotics were 73% (95% CI 52-92) and 49% (95% CI 28-70), respectively. Four studies 
reported on the proportion of women of childbearing age presenting with symptoms of UTI that 
were asked about their pregnancy status prior to antibiotics being supplied. The proportion 
ranged from 0% in a Spainish study 10 to 23% in a Saudi Arabian study.27  
Discussion 
This is the first study to provide pooled estimates of the extent of the supply of antibiotics 
without prescription. Despite regional variations, supplying antibiotics without prescription 
remains high globally. About three in four (78%) antibiotic requests and three in five (60%) 
consultations (in relation to symptoms of infectious diseases) in community pharmacies 
resulted in the supply of antibiotics without prescription. The majority of these antibiotics were 
supplied for the treatment of disease conditions that were largely acute and self-limiting 
including upper respiratory tract infections and gastroenteritis.  
Many of the antibiotics supplied without a prescription were broad-spectrum antibiotics 
including amoxicillin, amoxicillin-clavulanic acid, azithromycin and several fluoroquinolones. 
The use of broad-spectrum antibiotics increases the risk of the development of resistant 
infection including meticillin-resistant Staphylococcus aureus (MRSA). Broad-spectrum 
antibiotics were commonly recommended even in conditions where there are equally effective 
narrow spectrum antibiotics which can be used as first line therapies. For instance, 
fluoroquinolones were commonly recommended and supplied for uncomplicated urinary tract 
infections rather than the first-line narrow spectrum antibiotics such as trimethoprim and 
nitrofurantoin. Such use of fluoroquinolones can promote the development of resistant UTIs. 
A recent systematic review and meta-analysis estimating the global prevalence of antibiotic 
resistance in paediatric urinary tract infections caused by E.coli reported a pooled prevalence 
of 53.3% and 79.8% against ampicillin, and 2.1% and 26.8% against ciprofloxacin in OECD 
countries and countries outside OECD respectively.28 Over the counter sale of antibiotics in 
developing countries (outside OECD) was one of the reasons given by the authors to explain 
the higher prevalence of resistance.28 
Furthermore, the majority of the commonly supplied non-prescription antibiotics identified in 
our review including amoxicillin, azithromycin and the fluoroquinolones have been classified 
by the World Health Organisation as critically important antibiotics.29  This is because of their 
unique place in the treatment of infectious diseases including being the sole or one of the 
limited therapies for serious infections. For instance, macrolides remain part of a limited 
treatment option for Campylobacter infections especially in children, in whom fluoroquinolones 
are contraindicated.29 Therefore, the emergence of resistance to these antibiotics could have 
a significant impact on population health given the high and increasing incidence of 
campylobacter infections in children especially Campylobacter jejuni.30  
Results of this study also highlight some concerns around the safe supply and use of 
antibiotics. Even though the safety of fluoroquinolones in pregnancy have not been fully 
established, they were commonly supplied for UTIs to simulated patients who were of child-
bearing age without any check on their pregnancy status. In addition, only about one in three 
patients were asked if they have any known drug allergy during consultations. While antibiotics 
are largely perceived to be generally safe, serious adverse reactions including anaphylaxis 
have been associated with many of them.31 Therefore, we recommend that all antibiotics 
dispensing should have questions about allergy and pregnancy status in cases of women of 
childbearing age to enhance their safe use. 
Strict implementation of restrictions on over-the-counter sales of antibiotics has been shown 
to be effective in reducing non-prescription antibiotic consumption in Brazil, Chile and South 
Korea and Mexico.32-34  Given that many countries have laws prohibiting over-the-counter 
sales of antibiotics, there is a need to ensure that these laws are strictly enforced. However, it 
is important to understand that over-the-counter sale of some antibiotics may be supported in 
certain contexts. For example, in the UK, pharmacists legally supplied using a patient group 
direction,  azithromycin to patients with positive chlamydia test results.35 Legislative changes 
in some countries including Canada and New Zealand have given designated pharmacists the 
authority to prescribe and dispense antibiotics for some conditions. For instance, in New 
Zealand, pharmacists can prescribe and dispense trimethoprim for short-term treatment of an 
uncomplicated UTI.35   
Timely access and appropriate use of antibiotics have been associated with positive patient 
outcomes in several serious bacterial infections including pneumonia.36 A significant 
proportion of deaths caused by infections in many developing countries can be averted with 
early diagnosis and treatment. However, in many of these countries, access to healthcare 
facilities and prescribers are limited. Community pharmacies are often the first point of contact 
for the public.35, 37   Therefore, community pharmacists trained in antibiotic stewardship in 
these settings could play a significant role in ensuring prompt access to and rational use of 
antibiotics. They could deliver treatment for certain bacterial infections using standard 
treatment protocols, counsel patients on appropriate use of antibiotics, and prevent 
unnecessary use of antibiotics for non-bacterial infections through appropriate treatment of 
symptoms and counselling of patients to ensure they have a good understanding of their 
illness.35 Hence, promoting rational use of antibiotics rather than just restricting the supply of 
antibiotics without a prescription may be a more appropriate focus for any relevant policy in 
these settings.  
Finally, our study was limited by a lack of data from many countries. In addition, in countries 
where data were available, we included many small local/regional studies which may not 
necessarily reflect the extent of non-prescription supply of antibiotics across the whole nation. 
Geographical variations (urban vs rural) within the same country in terms of non-prescription 
supply of antibiotics cannot be ruled out. Therefore, our findings may have over or 
underrepresented the actual extent of non-prescription supply of antibiotics. Our findings could 
not take into account the impact of any national/regional policies targeted at reducing the 
supply of antibiotics without prescription, which was implemented after the publication of the 
included papers and has resulted in the reduction of non-prescription supply of antibiotics. We 
only looked at the supply of antibiotics without prescription but not antifungals or antivirals, 
which will be the focus of future research. Also, our aim was to estimate the global frequency 
of supplying antibiotics without a prescription but not to assess the association between non-
prescription supply of antibiotics and development of antibiotic resistance, an important area 
for future research. 
Conclusion 
This review provides the most robust and up-to-date global estimate of the proportion of over-
the-counter consultations and antibiotic requests that resulted in the dispensing of antibiotics 
without a prescription.  Despite the limitation of our review, the findings suggest that antibiotics 
are frequently supplied without prescription in many countries even where this supply remains 
illegal. This overuse of antibiotics could facilitate the development and spread of antibiotic 
resistance. Our findings underscore the need for countries to enforce laws that limit the supply 
of antibiotics without prescription in community pharmacies.  
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Box 1: Search strategy 
# Searches 
1 (antibiotic* or antimicrobial* or antibacterial*).af. 
2 (Non-prescri* or Sale* or Supply* or over the counter or Dispens* or Self-
medication).af. 
3 (community pharmac* or Pharmacy or pharmacies or Pharmacy shop* or Retail 
pharmac* or Shop* or Drug store* or Drug shop*).af. 
4 1 and 2 and 3  
5 limit 4 to year="2000 -Current" 
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Figure 1: Flow diagram of article selection process 
 
 
38 studies included in 
quantitative synthesis (meta-
analysis)  
3289 records identified through database 
searching (Medline 795, EMBASE 2328, 
CINAHL 166) 
13 additional records identified through 
other sources  
 
2619 records after duplicates removed  
2619 records screened  
 
2545 records excluded after 
reading titles and abstracts  
74 full-text articles assessed for 
eligibility  
 
36 full-text articles excluded 
Opinion-based survey (n= 14) 
Duplicate reports (n= 2) 
Reviews and letters (n= 7) 
Conference abstract (n=2) 
Qualitative studies (n=6) 
No relevant data (n=5) 
 
 Table 1 Characteristics of included studies 
Authors Study 
location 
Study design Methods Number of 
community 
pharmacies 
involved 
Number of 
interactions 
or 
consultations 
Proportion of 
dispensing of 
non-
prescribed 
antibiotics 
(%) 
Risk of bias 
classification 
Hussain et al.,38 Pakistan Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptom of upper 
respiratory tract infections 
(URTI) 
371 371 57.4 Moderate 
Puspitasari et 
al.,26 
Indonesia Cross-
sectional 
Simulated patient visits 
involving specific product 
request (ciprofloxacin 
tablets and tetracycline 
capsules) 
88 176 90.9 Low 
Almaaytah et 
al.,39 
Jordan Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptom of  URTI, 
gastroenteritis  and urinary 
tract infection (UTI) in  
women of childbearing age 
202 202 74.3 Low 
Gastelurrutia et 
al.,20 
Spain Cross-
sectional 
Simulated patient visits 
involving specific product 
requests and scenarios of 
symptoms of UTI  in  
women of childbearing age 
280 280 Product 
requests 
(16.3) and 
symptom-
based 
scenarios 
(18.7) 
Moderate 
Marković-
Peković and 
Grubisa,40  
Bosnia and 
Herzegovina 
Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
131 131 58 Moderate 
Plachouras et 
al., 41 
Greece Cross-
sectional 
Simulated patient visits 
involving specific product 
requests 
(amoxicillin/clavulanate 
acid or ciprofloxacin)  
174 174 72.4 Moderate 
Quagliarello et 
al., 25 
Vietnam Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI and 
gastroenteritis in children 
75 150 86.7 Low 
Shet et al., 42 India Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI in 
adults and gastroenteritis 
in children 
261 261 66.7 Low 
Volpato et al.,43 Brazil Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
107 107 74 Moderate 
Llor & Cots,44 Spain Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI, acute 
bronchitis and UTI in 
women of childbearing age 
197 197 45.2 Low 
Bin Abdulhak et 
al., 27 
Saudi 
Arabia 
Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI, acute 
bronchitis, otitis media, 
gastroenteritis and UTI in 
women of childbearing age 
aged women) 
327 327 77.6 Moderate 
Al-Faham et al., 
45 
Syria Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
200 200 87 Moderate 
Erku et al., 37 Ethiopia Cross-
sectional 
Simulated patient visits 
involving specific product 
requests (amoxicillin and 
clavulanic acid capsule) 
and scenarios of 
symptoms of  URTI 
31 62 Product 
requests 
(93.5) and 
symptom-
based 
scenarios 
(77.4) 
Moderate 
Diwan et al.,46 India Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of 
gastroenteritis in children 
164 164 40.2 Moderate 
Hoxha et al., 47 Albania cross-sectional Specific product request 323 323 80.2 Moderate 
Chang et al., 48 China cross-sectional Simulated patient visits 
involving scenarios of 
symptoms of URTI in 
adults and gastroenteritis 
in children 
256 512 68.8 Low 
Saengcharoen et 
al., 49 
Thailand Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
32 128 87.5 Low 
Contopoulos-
Ioannidis et al., 
[50] 
Greece Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
98 98 77.6 Low 
Vacca et al., 51 Columbia cross-sectional Simulated patient visits 
involving specific product 
requests  (amoxicillin, 
azithromycin, ciprofloxacin 
and trimethoprim / 
sulfamethoxazole ) and 
scenarios of symptoms of  
URTI, gastroenteritis, otitis 
media and UTI 
200 239 80.3 Low 
Saengcharoen & 
Lerkiatbundit,14 
Thailand cross-sectional Simulated patient visits 
involving scenarios of 
symptoms of acute 
gastroenteritis in children 
115 115 52.2 Low 
Al-Mohamadi et 
al., 21 
Saudi 
Arabia 
Cross-
sectional 
Simulated patient visits 
involving specific product 
requests (co-amoxiclav or 
cefaclor). 
60 60 97.6 Moderate 
Guinovart et al., 
10 
Spain Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI, acute 
bronchitis and UTI in 
women of childbearing 
age. 
220 220 54.1 Moderate 
Chalker et al., 52 Vietnam cross-sectional Simulated patient visits 
involving scenarios of 
symptoms of sexually 
transmitted diseases 
(STD) 
60 295 81.5 Moderate 
Kalungia et al.,53 Zambia Cross-
sectional 
structured interviewer-
administered questionnaire 
with simulated case 
scenarios of symptoms of 
URTI and UTI in 
pregnancy 
73 146 71.2 Moderate 
Ibrahim et al.,54 Qatar cross-sectional Simulated patient visits 
involving scenarios of 
symptoms of acute 
gastroenteritis 
30 60 43.9 Moderate 
Chuc et al., 55 Vietnam Randomized 
controlled trial 
Simulated patient visits 
involving specific product 
requests and scenarios of 
symptoms of  
uncomplicated URTI in a 
child and STD in an adult 
in an adult man 
58 116 Product 
requests 
(94.8) and 
symptom-
based 
scenarios 
(41.1) 
Low 
Salunkhe et al., 
23 
India cross-sectional Simulated patient visits 
involving scenarios of 
symptoms of URTI or 
diarrhoea 
263 263 94.3 Moderate 
Jaganathan et 
al., 56 
India Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of acute 
gastroenteritis and URTI 
120 120 72.5 Moderate 
Amin et al., 57 Egypt Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
104 104 65.4 Low 
Satyanarayana 
et al., 15 
India Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of pulmonary 
tuberculosis (TB) 
622 1200 27 Low 
Nyazema et al., 
22 
Zimbabwe Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of STD and 
gastroenteritis 
87 184 8.2 Moderate 
Alabid et al., 58 Malaysia Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
50 100 32 Moderate 
Malik et al., 59 Pakistan Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of malaria 
238 238 28.6 Moderate 
Bell et al., 60  Cambodia Cross-
sectional 
 Interviewer-administered 
questionnaire with 
simulated case scenarios 
of TB 
170 170 24.1 Low 
Al-Ghamdi 61 Saudi 
Arabia 
Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of UTI 
88 88 81.8 Moderate 
Homedes and 
Ugalde, 62 
Mexico Cross-
sectional 
 Interviewer-administered 
questionnaire with 
simulated case scenarios 
of URTI and gastroenteritis 
25 49 71.4 Moderate 
Marković-
Peković et al 24 
Bosnia and 
Herzegovina 
Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
383 383 18.5 Low 
Okuyan et al 63 Turkey Cross-
sectional 
Simulated patient visits 
involving scenarios of 
symptoms of URTI 
70 70 45.7 Moderate 
 
  
 
Figure 2:  Meta-analysis for the overall pooled proportion of non-prescription supply 
of antibiotics 
 
  
 
Figure 3: Country level estimates of non-prescription supply of antibiotics 
  
Figure 4:  Meta-analysis for the proportion of non-prescription supply of antibiotics 
based on pharmacy staff recommendation 
 
 
 
 
 
Table 2: Subgroup meta-analysis of the proportion of non-prescription supply of 
antibiotics 
Subgroup Estimate % (95%CI) No. studies Heterogeneity 
Region 
Asia 
 
65 (54 – 76) 
 
23 
 
I2 = 99.1%, p < 0.001 
Africa 57 (16 – 99) 4 I2 = 99.3%, p < 0.001 
Europe 53 (33 – 73) 8 I2 = 98.7%, p < 0.001 
South America 78 (72 – 84) 2 I2 = 38.0%, p = 0.204 
North America 71 (59 – 84) 1 ND 
Study period 
2011 - 2017 
 
56 (43 – 69) 
 
7 
 
I2 = 99.1%, p < 0.001 
2006 - 2010 62 (43 – 81) 12 I2 = 99.4%, p < 0.001 
2000 - 2005 80 (76 – 85) 19 I2 = 71.8%, p = 0.002 
Number of community 
pharmacies included 
≥ 100 
 
 
58 (46 – 70) 
 
 
23 
 
 
I2 = 99.2%, p < 0.001 
< 100 69 (52 – 85) 15 I2 = 99.0%, p < 0.001 
Type of scenario 
Direct product request 
 
85 (75 – 94) 
 
4 
 
I2 = 93.9%, p < 0.001 
Symptom-based 59 (49 – 70) 30 I2 = 99.1%, p < 0.001 
Mixed* 63 (26 – 99) 4 I2 = 99.3%, p < 0.001 
Category of pharmacy 
staff 
Pharmacist only 
 
 
59 (32 – 87) 
 
 
5 
 
 
I2 = 98.2%, p < 0.001 
Mixed** 58 (42 – 74) 12 I2 = 99.0%, p < 0.001 
Unspecified 65 (52 - 78) 21 I2 = 99.3%, p < 0.001 
Concealment in 
methodology 
Yes  
 
 
63 (53 - 73) 
 
 
35 
 
 
I2 = 99.1%, p < 0.001 
No 55 (21 – 90) 3 I2 = 98.1%, p < 0.001 
*studies that employed both direct product request and symptom-based scenario.  **studies that included a 
variety of pharmacy staff, ND – not determined 
 
Table 3: Pooled estimates on the proportion of antibiotics supplied without a 
prescription by disease category 
Symptom category Estimate % (95% CI) No. studies Heterogeneity 
URTI 67 (55–79) 23 I2 = 98.7%, p < 0.001 
Bronchitis 42 (34-49) 2 I2 = 98.5%, p < 0.001 
Otitis media 57 (47-68) 2 I2 = 57.0%, p = 0.127 
Gastroenteritis 63 (46-80) 12 I2 = 98.6%, p < 0.001 
UTI 68 (42-93) 6 I2 = 97.8%, p < 0.001 
STD 47 (44-51) 2 I2 = 99.8%, p < 0.001 
Pulmonary TB 27 (24-29) 2 I2 = 0.0%, p = 0.410 
Malaria 29 (23-34) 1 ND 
ND – not determined 
 
 
 
Figure 5: Classes of antibiotics supplied without prescription for Gastroenteritis, URTI 
and UTI 
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Table 4: Nature of counselling provided during consultation  
Nature of counselling Estimate % (95% CI) No. studies Heterogeneity 
Asked patients about 
allergy 
32 (11-53) 10 I2 = 99.4%, p < 0.001 
Asked patients about 
any medicines they are 
taking 
12 (4-19) 6 I2 = 96.1%, p < 0.001 
Asked female patients 
of child-bearing age 
about pregnancy status 
8 (1-18) 4 I2 = 82.5%, p = 0.003 
Explained the dose of  
antibiotics 
73 (52-92) 11 I2 = 99.2%, p < 0.001 
Explained how long to 
take the antibiotics 
49 (28-70) 12 I2 = 99.2%, p < 0.001 
Referred patients to a 
physician 
21 (14-28) 16 I2 = 97.8%, p < 0.001 
 
 
 
